曲美他嗪对冠心病心力衰竭患者心脏收缩和舒张功能的影响

刘东; 黄晶; 邓昌明; 高大中; 李增高

doi:10.13406/j.cnki.cyxb.2003.06.038

您当前的位置：

首页 >

文章列表页 >

曲美他嗪对冠心病心力衰竭患者心脏收缩和舒张功能的影响

更新时间：2024-01-17

- 曲美他嗪对冠心病心力衰竭患者心脏收缩和舒张功能的影响
- Effect of trimetazidine on cardiac systolic and diastolic function in patients with chronic congestive heart failure due to coronary artery disease
- 重庆医科大学学报 2003年第6期页码：804-806
- 作者机构：
  
  1. 重庆医科大学第二临床学院心内科
  2. 重庆医科大学第二临床学院心内科,重庆,400010
- 作者简介：
- 基金信息：
- DOI：10.13406/j.cnki.cyxb.2003.06.038
  中图分类号： R541.6
- 纸质出版日期：2003，
扫描看全文
[1]刘东,黄晶,邓昌明,高大中,李增高.曲美他嗪对冠心病心力衰竭患者心脏收缩和舒张功能的影响[J].重庆医科大学学报,2003(06):804-806.

LIU Dong, et al. Effect of trimetazidine on cardiac systolic and diastolic function in patients with chronic congestive heart failure due to coronary artery disease[J]. Journal of Chongqing Medical University, 2003,(6):804-806.
[1]刘东,黄晶,邓昌明,高大中,李增高.曲美他嗪对冠心病心力衰竭患者心脏收缩和舒张功能的影响[J].重庆医科大学学报,2003(06):804-806. DOI： 10.13406/j.cnki.cyxb.2003.06.038.

LIU Dong, et al. Effect of trimetazidine on cardiac systolic and diastolic function in patients with chronic congestive heart failure due to coronary artery disease[J]. Journal of Chongqing Medical University, 2003,(6):804-806. DOI： 10.13406/j.cnki.cyxb.2003.06.038.

摘要

目的 :探讨曲美他嗪对冠心病慢性心力衰竭患者心脏收缩和舒张功能的影响。方法 :观察冠心病慢性心力衰竭患者4 5例

其中曲美他嗪组 2 3例

对照组 2 2例。分别测定用药前及用药 6月后两组患者的超声心动图心功能指标SV

CIandLVEF

VA/VE。结果 :用药 6月后曲美他嗪组患者的SV

CI及LVEF较对照组显著增高（P <0 .0 5 ）

但VA

VE及VA/VE与对照组相比无显著性差异（P >0 .0 5 ）。结论 :曲美他嗪通过改善缺血心肌细胞的能量代谢

可保护缺血心肌细胞的功能

从而改善心脏的收缩功能。

Abstract

Objective:To investigate the effects of trimetazidine on cardiac systolic and diastolic function in patients with chronic congestive heart failure due to coronary artery disease.Methods:45 patients with chronic congestive heart failure due to coronary artery disease were divided into two groups

23 patients in trimetazidine group and 22 in placebo-control group.The echocardiogram indices of cardiac function of patients in two groups-SV

LVEF

VE and VA/VE were measured before and after treatment.Results:The indexes SV

CI and LVEF were significantly higher in trimetazidine group than those in control group(P<0.05)

but no significant difference in VA

VE and VA/VE was observed between the two groups(P>0.05).Conclusion:Trimetazidine can improve systolic function of ischemic heart by improving the energy metabolism of ischemic heart.

关键词

曲美他嗪冠心病心力衰竭心功能

Keywords

Trimetazidinecoronary artery diseaseheart failurecardiac function

references

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

心音图在心绞痛患者中的临床诊断价值

晚期肺癌炎症指数预测房颤合并心衰患者预后的价值

糖尿病肾病患者血清HMGB1和TNF-α水平与心功能的相关性研究

远隔器官后适应联合依达拉奉对急性心肌梗死患者心肌缺血再灌注损伤作用的研究

雷帕霉素对早期心力衰竭大鼠心肌细胞自噬功能的影响及意义